Funder: Pfizer Inc.

Due Dates: April 15, 2026 (full proposal submission, 23:59 Eastern Time)

Funding Amounts: Up to C$100,000 per project; total program budget C$300,000; project duration up to 24 months

Summary: Supports research and quality improvement projects to enhance and accelerate biomarker testing for colorectal cancer patients across Canada, aiming to improve treatment decisions and patient outcomes.

Key Information: Only Canadian organizations/institutions may apply; projects must address metastatic colorectal cancer.